Supporting ICH may harmonise standards

Participating in working groups on current topics at the International Council for Harmonisation (ICH) may help industry achieve its goal of single, global development programs for generics and biosimilars, according to Nick Cappuccino, one of two representatives for the International Generic and Biosimilar Medicines Association (IGBA) on the ICH’s management committee.

Commenting on the IGBA’s role following the association’s election this month to the ICH management committee for a three-year term (Generics bulletin, 15 June 2018, page 1), Dr Reddy’s executive Cappuccino appealed for IGBA member companies to get involved in ICH working groups on a broad range of topics